News
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.46 per share versus the Zacks Consensus Estimate of a loss of $6.4. This compares to a loss of $11.2 per share a year ago
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates
IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago. These figures
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates
RenovoRx, Inc. (RNXT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago. These figures are adjusted
Evolv Technologies Holdings, Inc. (EVLV) Reports Q2 Loss, Beats Revenue Estimates
Evolv Technologies Holdings, Inc. (EVLV) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.02 per share a year
Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates
Profound Medical (PROF) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.28 per share a year ago. These figures
Guidance Watch: 2 Companies Bullishly Raising Forecasts
The 2025 Q2 earnings cycle is slowly winding down, which has been resilient so far.
For the 457 S&P 500 companies that have reported Q2 results as of August 13th, total earnings are up +11.6% from
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago. These
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to earnings of $1.52 per share a year ago. These
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenics (MGNX) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.89 per share a year ago. These figures are
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates
Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.25 per share a year ago. These
Applied Materials (AMAT) Q3 Earnings and Revenues Beat Estimates
Applied Materials (AMAT) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $2.34 per share. This compares to earnings of $2.12 per share a year ago. These
Do Options Traders Know Something About FBIZ Stock We Don't?
Investors in First Business Financial Services, Inc. FBIZ need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $55 Call had some
Is the Options Market Predicting a Spike in Hope Bancorp Stock?
Investors in Hope Bancorp, Inc. HOPE need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $7.5 Call had some of the highest
Buy or Avoid the Drop in Chipotle & Cava Group's Stock?
Known for generating massive gains for investors, Chipotle CMG and Cava Group CAVA have seen their stocks fall mightily to 52-week lows following their lackluster Q2 results.
This comes as the Zacks
Top Analyst Reports for Merck, Palo Alto & Freeport
Thursday, August 14, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Merck &
TOMI Environmental Solutions, Inc. (TOMZ) Reports Q2 Loss, Lags Revenue Estimates
TOMI Environmental Solutions, Inc. (TOMZ) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to break-even earnings per share a
Nuclear Reactors on the Moon? Why BWX Technologies Is Soaring
Nuclear energy stocks have been all the rage recently. Demonstrating this is the return of the VanEck Uranium and Nuclear ETF (NYSEARCA: NLR). As of the Aug. 12 close, NLR has provided a total
Buy the Gold Mining Stocks Right Now
- (1:00) - Where Should Investors Be Looking To Gain Exposure To Gold Right Now
- (6:50) - These ETF’s Can Help You Invest Into Gold
- (15:40) - Individual Stocks To Keep On Your Radar For Gold
QBTS Stock Jumps After Q2 But Profit Woes Cloud Outlook: Time to Sell?
D-Wave Quantum’s QBTS stock has risen 8.6% since its Aug. 7, 2025 second-quarter earnings release despite a miss as investors cheered business momentum and customer growth. Revenues jumped 42% year
Tredegar's Q2 Earnings Slide Y/Y on Cost, Volume Pressures
Shares of Tredegar Corporation TG have declined 7.1% since the company reported its earnings for the quarter ended June 30, 2025, compared to a 1.7% gain for the S&P 500 index over the same period
NERA's Q2 Earnings Improve Y/Y on Portfolio Expansion, Stock Down 1%
Shares of New England Realty Associates Limited Partnership NEN have dipped 0.7% since the company reported its earnings for the quarter ended June 30, 2025. This compares to the S&P 500 index’s
Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore
Shares of Gartner Inc. (NYSE: IT) are trading just over $240, down from $340 barely two weeks ago. The stock had already been trending lower since February, but few could have predicted the


